News CANARIABIO Inc.

Equities

A016790

KR7016790008

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-02-28 pm EST			5-day change	1st Jan Change
994 ^KRW	+8.52%		-.--%	-80.70%

Mar. 29	CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index	CI
Jan. 24	Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index	Mar. 28	CI
Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis	Jan. 24	MT
CANARIABIO Inc. announced that it has received KRW 4.999995308 billion in funding from CANARIABIO M Inc.	Dec. 27	CI
CANARIABIO Inc. announced that it expects to receive KRW 4.999995308 billion in funding from CANARIABIO M Inc.	Dec. 19	CI
Specialised Therapeutics Asia Pte Ltd Signs Exclusive License Agreement with CanariaBio for New Ovarian Cancer Therapy	23-10-12	CI
Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa	23-10-11	AQ
CanariaBio Inc. Announces Enrollment Completion of Phase 2 Study of Oregovomab in Combination with Niraparib in the Treatment of Recurrent Ovarian Cancer	23-08-08	CI
CANARIABIO Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
An Unknown buyer agreed to acquire 2.133768% stake in CANARIABIO Inc. from CANARIABIO M Inc. for KRW 14 billion.	23-02-13	CI
CANARIABIO Inc. announced that it has received KRW 15 billion in funding from AT semicon Co., Ltd.	23-01-15	CI
CANARIABIO Inc. announced that it has received KRW 10 billion in funding from AT semicon Co., Ltd.	23-01-12	CI
CANARIABIO Inc. announced that it has received KRW 10 billion in funding from CANARIABIO Inc.	22-12-27	CI
CANARIABIO Inc. announced that it has received KRW 30 billion in funding from CANARIABIO M Inc.	22-12-18	CI
CANARIABIO Inc. announced that it has received KRW 20 billion in funding from CANARIABIO M Inc.	22-11-16	CI
CANARIABIO Inc. announced that it expects to receive KRW 20 billion in funding from CANARIABIO M Inc.	22-11-14	CI
CANARIABIO Inc. announced that it expects to receive KRW 30 billion in funding from CANARIABIO M Inc.	22-11-14	CI
CANARIABIO Inc. announced that it has received KRW 80 billion in funding from CANARIABIO M Inc.	22-10-11	CI
CANARIABIO Inc. announced that it has received KRW 29.999997555 billion in funding from Sejong Medical Co., Ltd.	22-10-11	CI
CANARIABIO Inc. announced that it expects to receive KRW 19.99999837 billion in funding from Sejong Medical Co., Ltd.	22-10-03	CI
CANARIABIO Inc.(KOSDAQ:A016790) added to S&P Global BMI Index	22-09-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News CANARIABIO Inc.

Equities

A016790

KR7016790008

Summary

Filters